Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;20(4):1325-1330.
doi: 10.1111/jocd.13729. Epub 2020 Oct 5.

Systemic dexpanthenol as a novel treatment for female pattern hair loss

Ömer Kutlu  1 , Ahmet Metin  2
Affiliations

Systemic dexpanthenol as a novel treatment for female pattern hair loss

Ömer Kutlu et al. J Cosmet Dermatol. 2021 Apr.

Abstract

Background: There are only a few drugs that have been used for the treatment of female pattern hair loss (FPHL).

Aims: Through use of the Dermatologic Life Quality Index (DLQI) and a modified hair growth questionnaire, we aimed to evaluate the effect of dexpanthenol (DXP) as a new option for FPHL.

Methods: Women who received 500 mg intramuscular DXP weekly for FPHL were included in this study. They were evaluated in terms of DLQI and laboratory characteristics, before and after DXP treatment, and were examined with a modified hair growth questionnaire.

Results: Overall satisfaction with the appearance of the hair was described by the patients as 57.1% " I am satisfied," 28.6% "I am very satisfied," and 14.3% "I am neutral (neither satisfied nor dissatisfied)." There was a statistical difference between the mean DLQI scores before and after DXP treatment (P < .001). No statistical difference was found in the laboratory characteristics of the patients before and after DXP treatment (P > 0.05). No side effect was reported during DXP treatment.

Conclusion: Dexpanthenol is a safe and novel drug that may increase the quality of life in patients with FPHL.

Keywords: androgenetic alopecia; dexpanthenol; female pattern hair loss.

PubMed Disclaimer

References

REFERENCES

    1. Ramos PM, Miot HA. Female pattern hair loss: a clinical and pathophysiological review. An Bras Dermatol. 2015;90(4):529-543.
    1. Messenger A. Hair through the female life cycle. Br J Dermatol. 2011;165:2-6.
    1. Trüeb RM. Molecular mechanisms of androgenetic alopecia. Exp Gerontol. 2002;37(8-9):981-990.
    1. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview...
    1. Li-Mei W, Jie T, Shan-He W, Dong-Mei M, Peng-Jiu Y. Anti-inflammatory and anti-oxidative effects of dexpanthenol on lipopolysaccharide induced acute lung injury in mice. Inflammation. 2016;39(5):1757-1763.

LinkOut - more resources